Neil E. Stahl

Insider Reports History

Location
Tarrytown, NY
Signature
/s/ Neil E. Stahl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil E. Stahl:

Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
48,829
Estimated value
$35,684,721
Report date
16 Dec 2024
Price
$730.81
Ownership
Direct
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
5,849
Estimated value
$4,274,508
Report date
16 Dec 2024
Price
$730.81
Ownership
By 401(k) Plan
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
4,605
Estimated value
$3,365,380
Report date
16 Dec 2024
Price
$730.81
Ownership
by Spouse as Trustee
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
45,000
Estimated value
Report date
02 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
02 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Neil E. Stahl

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .